Literature DB >> 638914

Diffuse lung changes associated with gold therapy.

S M Sepuya, S Grzybowski, J D Burton, J G Clement.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 638914      PMCID: PMC1818194     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Lung changes during hexamethonium therapy for hypertension.

Authors:  I DONIACH; B MORRISON; R E STEINER
Journal:  Br Heart J       Date:  1954-01

Review 2.  The spectrum of drug-induced pulmonary disease.

Authors:  E C Rosenow
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

3.  Immunological studies on the mechanism of gold hypersensitivity reactions.

Authors:  P Davis; A Ezeoke; J Munro; J R Hobbs; G R Hughes
Journal:  Br Med J       Date:  1973-09-29

4.  Pulmonary complications of drug therapy.

Authors:  A Brettner; E R Heitzman; W G Woodin
Journal:  Radiology       Date:  1970-07       Impact factor: 11.105

5.  Chronic nitrofurantoin pulmonary reaction. Report of 5 cases.

Authors:  E C Rosenow; R A DeRemee; D E Dines
Journal:  N Engl J Med       Date:  1968-12-05       Impact factor: 91.245

6.  Busulphan lung.

Authors:  B E Heard; R A Cooke
Journal:  Thorax       Date:  1968-03       Impact factor: 9.139

7.  Fibrotic disorders associated with methysergide therapy for headache.

Authors:  J R Graham; H I Suby; P R LeCompte; N L Sadowsky
Journal:  N Engl J Med       Date:  1966-02-17       Impact factor: 91.245

8.  Nephrotoxic effect of parenteral and intraarticular gold. Ultrastructure and electron microprobe examination of clinical and experimental material.

Authors:  R Yarom; H Stein; P D Peters; S Slavin; T A Hall
Journal:  Arch Pathol       Date:  1975-01

9.  Diffuse pulmonary injury associated with gold treatment.

Authors:  R H Winterbauer; K R Wilske; R F Wheelis
Journal:  N Engl J Med       Date:  1976-04-22       Impact factor: 91.245

  9 in total
  5 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  Adverse reactions with oral and parenteral gold preparations.

Authors:  E C Tozman; N L Gottlieb
Journal:  Med Toxicol       Date:  1987 May-Jun

3.  Fatal intrahepatic cholestasis and interstitial lung fibrosis following gold therapy for rheumatoid arthritis.

Authors:  M R Shaban; D N Golding; R G Letcher
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

4.  Gold-induced lung disease.

Authors:  J Heyd; A Simmeran
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

5.  Fatal bronchiolitis obliterans associated with chrysotherapy.

Authors:  L Holness; J Tenenbaum; N B Cooter; R F Grossman
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.